Antonio Oliver (A Oliver)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 71

Top Topics

Pseudomonas Aeruginosa

Multidrug Resistant

Binding Protein

Cystic Fibrosis

Top Venues

Antimicrobial agents and chemotherapy

Microbiology spectrum

Microbiology and molecular biology reviews : MMBR

This page only lists publications with an associated author ORCID identifier.

Publications

María Escobar-Salom, Isabel María Barceló, Estrella Rojo-Molinero, Elena Jordana-Lluch, Gabriel Cabot, Antonio Oliver, Carlos Juan
In vitro activity of human defensins HNP-1 and hBD-3 against multidrug-resistant ESKAPE Gram-negatives of clinical origin and selected peptidoglycan recycling-defective mutants. Microbiology spectrum 12 (4) (2024)
Isabel M Barceló, Maria Escobar-Salom, Gabriel Cabot, Pau Perelló-Bauzà, Elena Jordana-Lluch, Biel Taltavull, Gabriel Torrens, Estrella Rojo-Molinero, Laura Zamorano, Astrid Pérez, Antonio Oliver, Carlos Juan
Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications. Antimicrobial agents and chemotherapy (2024)
Isabel M Barceló, Maria Escobar-Salom, Gabriel Cabot, Pau Perelló-Bauzà, Elena Jordana-Lluch, Biel Taltavull, Gabriel Torrens, Estrella Rojo-Molinero, Laura Zamorano, Astrid Pérez, Antonio Oliver, Carlos Juan
Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications. Antimicrobial agents and chemotherapy 68 (5) (2024)
H Li, Antonio Oliver, Ryan K Shields, S Kamat, G Stone, M Estabrook
Molecular characterization of clinically isolated Pseudomonas aeruginosa with varying resistance to ceftazidime-avibactam and ceftolozane-tazobactam collected as a part of the ATLAS global surveillance program from 2020 to 2021. Antimicrobial agents and chemotherapy (2024)
Isabel M Barceló, María Escobar-Salom, Gabriel Cabot, Pau Perelló-Bauzà, Elena Jordana-Lluch, Biel Taltavull, Gabriel Torrens, Estrella Rojo-Molinero, Laura Zamorano, Astrid Pérez, Antonio Oliver, Carlos Juan
Correction for Barceló et al., "Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications". Antimicrobial agents and chemotherapy 68 (7) (2024)
Isabel M Barceló, María Escobar-Salom, Gabriel Cabot, Pau Perelló-Bauzà, Elena Jordana-Lluch, Biel Taltavull, Gabriel Torrens, Estrella Rojo-Molinero, Laura Zamorano, Astrid Pérez, Antonio Oliver, Carlos Juan
Correction for Barceló et al., "Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications". Antimicrobial agents and chemotherapy (2024)
Ricardo Arcay, Maria Barceló-Nicolau, Loreto Suárez, Luisa Martín, Rebeca Reigada, Marcus Höring, Gerhard Liebisch, Carmen Garrido, Gabriel Cabot, Helem H Vilchez, Sara Cortés-Lara, Elisa González de Herrero, Carla López-Causapé, Antonio Oliver, Gwendolyn Barceló-Coblijn, Ana Mena
Gut microbiome and plasma lipidome analysis reveals a specific impact of Clostridioides difficile infection on intestinal bacterial communities and sterol metabolism. mBio (2024)
María Escobar-Salom, Isabel María Barceló, Estrella Rojo-Molinero, Elena Jordana-Lluch, Gabriel Cabot, Antonio Oliver, Carlos Juan
In vitro activity of human defensins HNP-1 and hBD-3 against multidrug-resistant ESKAPE Gram-negatives of clinical origin and selected peptidoglycan recycling-defective mutants. Microbiology spectrum (2024)
Anne Santerre Henriksen, Katy Jeannot, Antonio Oliver, John D Perry, Mathias W Pletz, Stefania Stefani, Ian Morrissey, Christopher M Longshaw, null null
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations. Microbiology spectrum 12 (4) (2024)
Isabel M Barceló, María Escobar-Salom, Gabriel Cabot, Pau Perelló-Bauzà, Elena Jordana-Lluch, Biel Taltavull, Gabriel Torrens, Estrella Rojo-Molinero, Laura Zamorano, Astrid Pérez, Antonio Oliver, Carlos Juan
Correction for Barceló et al., "Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications". Antimicrobial agents and chemotherapy 68 (7) (2024)
María Escobar-Salom, Isabel María Barceló, Estrella Rojo-Molinero, Elena Jordana-Lluch, Gabriel Cabot, Antonio Oliver, Carlos Juan
In vitro activity of human defensins HNP-1 and hBD-3 against multidrug-resistant ESKAPE Gram-negatives of clinical origin and selected peptidoglycan recycling-defective mutants. Microbiology spectrum 12 (4) (2024)
María Escobar-Salom, Isabel María Barceló, Estrella Rojo-Molinero, Elena Jordana-Lluch, Gabriel Cabot, Antonio Oliver, Carlos Juan
In vitro activity of human defensins HNP-1 and hBD-3 against multidrug-resistant ESKAPE Gram-negatives of clinical origin and selected peptidoglycan recycling-defective mutants. Microbiology spectrum 12 (4) (2024)
Isabel M Barceló, Maria Escobar-Salom, Gabriel Cabot, Pau Perelló-Bauzà, Elena Jordana-Lluch, Biel Taltavull, Gabriel Torrens, Estrella Rojo-Molinero, Laura Zamorano, Astrid Pérez, Antonio Oliver, Carlos Juan
Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications. Antimicrobial agents and chemotherapy 68 (5) (2024)
Anne Santerre Henriksen, Katy Jeannot, Antonio Oliver, John D Perry, Mathias W Pletz, Stefania Stefani, Ian Morrissey, Christopher M Longshaw, null null
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations. Microbiology spectrum 12 (4) (2024)
Anne Santerre Henriksen, Katy Jeannot, Antonio Oliver, John D Perry, Mathias W Pletz, Stefania Stefani, Ian Morrissey, Christopher M Longshaw, null null
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations. Microbiology spectrum 12 (4) (2024)
Isabel M Barceló, Maria Escobar-Salom, Gabriel Cabot, Pau Perelló-Bauzà, Elena Jordana-Lluch, Biel Taltavull, Gabriel Torrens, Estrella Rojo-Molinero, Laura Zamorano, Astrid Pérez, Antonio Oliver, Carlos Juan
Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications. Antimicrobial agents and chemotherapy 68 (5) (2024)
Anne Santerre Henriksen, Katy Jeannot, Antonio Oliver, John D Perry, Mathias W Pletz, Stefania Stefani, Ian Morrissey, Christopher M Longshaw, null null
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations. Microbiology spectrum (2024)
Isabel M Barceló, Maria Escobar-Salom, Gabriel Cabot, Pau Perelló-Bauzà, Elena Jordana-Lluch, Biel Taltavull, Gabriel Torrens, Estrella Rojo-Molinero, Laura Zamorano, Astrid Pérez, Antonio Oliver, Carlos Juan
Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications. Antimicrobial agents and chemotherapy 68 (5) (2024)
Silvia López-Argüello, Maria Montaner, Amanda Mármol-Salvador, Ana Velázquez-Escudero, Fernando Docobo-Pérez, Antonio Oliver, Bartolome Moya
Penicillin-Binding Protein Occupancy Dataset for 18 β-Lactams and 4 β-Lactamase Inhibitors in Neisseria gonorrhoeae. Microbiology spectrum (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
Silvia López-Argüello, Maria Montaner, Amanda Mármol-Salvador, Ana Velázquez-Escudero, Fernando Docobo-Pérez, Antonio Oliver, Bartolome Moya
Penicillin-Binding Protein Occupancy Dataset for 18 β-Lactams and 4 β-Lactamase Inhibitors in Neisseria gonorrhoeae. Microbiology spectrum (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy (2023)
Silvia López-Argüello, Maria Montaner, Alaa Rm Sayed, Antonio Oliver, Juergen B Bulitta, Bartolome Moya
Penicillin-Binding Protein 5/6 Acting as a Decoy Target in Pseudomonas aeruginosa Identified by Whole-Cell Receptor Binding and Quantitative Systems Pharmacology. Antimicrobial agents and chemotherapy (2023)
Silvia López-Argüello, Maria Montaner, Amanda Mármol-Salvador, Ana Velázquez-Escudero, Fernando Docobo-Pérez, Antonio Oliver, Bartolome Moya
Penicillin-Binding Protein Occupancy Dataset for 18 β-Lactams and 4 β-Lactamase Inhibitors in Neisseria gonorrhoeae. Microbiology spectrum (2023)
María A Gomis-Font, María A Clari, Carla López-Causapé, David Navarro, Antonio Oliver
Emergence of cefiderocol resistance during ceftazidime/avibactam treatment caused by a large genomic deletion, including ampD and piuCD genes, in Pseudomonas aeruginosa . Antimicrobial agents and chemotherapy (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
Gabriel Cabot, Ki-Hun Kim, Brian L Mark, Antonio Oliver, Mazdak Khajehpour
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 67 (2) (2023)
Jessica R Tait, Marina Harper, Sara Cortés-Lara, Kate E Rogers, Carla López-Causapé, Thomas R Smallman, Yinzhi Lang, Wee Leng Lee, Jieqiang Zhou, Juergen B Bulitta, Roger L Nation, John D Boyce, Antonio Oliver, Cornelia B Landersdorfer
Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance. Antimicrobial agents and chemotherapy (2023)
Fernando Sanz-García, Sara Hernando-Amado, Carla López-Causapé, Antonio Oliver, José-Luis Martínez
Low Ciprofloxacin Concentrations Select Multidrug-Resistant Mutants Overproducing Efflux Pumps in Clinical Isolates of Pseudomonas aeruginosa. Microbiology spectrum 10 (5) (2022)
Isabel M Barceló, Elena Jordana-Lluch, María Escobar-Salom, Gabriel Torrens, Pablo A Fraile-Ribot, Gabriel Cabot, Xavier Mulet, Laura Zamorano, Carlos Juan, Antonio Oliver
Role of Enzymatic Activity in the Biological Cost Associated with the Production of AmpC β-Lactamases in Pseudomonas aeruginosa. Microbiology spectrum 10 (5) (2022)
Marta Hernandez-García, María García-Castillo, Germán Bou, Emilia Cercenado, Mercedes Delgado-Valverde, Antonio Oliver, Cristina Pitart, Jesús Rodríguez-Lozano, Nuria Tormo, José Melo-Cristino, Margarida F Pinto, Elsa Gonçalves, Valquíria Alves, Ana Raquel Vieira, Elmano Ramalheira, Luísa Sancho, José Diogo, Rui Ferreira, Hugo Cruz, Catarina Chaves, Joana Duarte, Leonor Pássaro, Jazmín Díaz-Regañón, Rafael Cantón
Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies). Microbiology spectrum 10 (5) (2022)
Hajira Bilal, Jessica R Tait, Yinzhi Lang, Jieqiang Zhou, Phillip J Bergen, Anton Y Peleg, Juergen B Bulitta, Antonio Oliver, Roger L Nation, Cornelia B Landersdorfer
Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling. Antimicrobial agents and chemotherapy 66 (3) (2022)
Maria Montaner, Silvia Lopez-Argüello, Antonio Oliver, Bartolome Moya
PBP Target Profiling by β-Lactam and β-Lactamase Inhibitors in Intact Pseudomonas aeruginosa: Effects of the Intrinsic and Acquired Resistance Determinants on the Periplasmic Drug Availability. Microbiology spectrum (2022)
Sara Hernando-Amado, Carla López-Causapé, Pablo Laborda, Fernando Sanz-García, Antonio Oliver, José-Luis Martínez
Rapid Phenotypic Convergence towards Collateral Sensitivity in Clinical Isolates of Pseudomonas aeruginosa Presenting Different Genomic Backgrounds. Microbiology spectrum 11 (1) (2022)
Sara Hernando-Amado, Carla López-Causapé, Pablo Laborda, Fernando Sanz-García, Antonio Oliver, José-Luis Martínez
Rapid Phenotypic Convergence towards Collateral Sensitivity in Clinical Isolates of Pseudomonas aeruginosa Presenting Different Genomic Backgrounds. Microbiology spectrum 11 (1) (2022)
Berta Puig-Collderram, Sandra Domene-Ochoa, Maria Salvà-Comas, Maria Milagro Montero, Xavier Duran, Juan R González, Santiago Grau, Antonio Oliver, Juan Pablo Horcajada, Eduardo Padilla, Concepción Segura, Núria Prim
ATP Bioluminescence Assay To Evaluate Antibiotic Combinations against Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa. Microbiology spectrum 10 (4) (2022)
Sara Hernando-Amado, Carla López-Causapé, Pablo Laborda, Fernando Sanz-García, Antonio Oliver, José-Luis Martínez
Rapid Phenotypic Convergence towards Collateral Sensitivity in Clinical Isolates of Pseudomonas aeruginosa Presenting Different Genomic Backgrounds. Microbiology spectrum (2022)
Isabel M Barceló, Gabriel Torrens, María Escobar-Salom, Elena Jordana-Lluch, María Magdalena Capó-Bauzá, Carlos Ramón-Pallín, Daniel García-Cuaresma, Pablo A Fraile-Ribot, Xavier Mulet, Antonio Oliver, Carlos Juan
Impact of Peptidoglycan Recycling Blockade and Expression of Horizontally Acquired β-Lactamases on Pseudomonas aeruginosa Virulence. Microbiology spectrum 10 (1) (2022)
María Milagro Montero, Sandra Domene-Ochoa, Carla López-Causapé, Inmaculada López-Montesinos, Sonia Luque, Luisa Sorlí, Núria Campillo, Eduardo Padilla, Núria Prim, Lorena Ferrer Alapont, Santiago Grau, Antonio Oliver, Juan Pablo Horcajada
Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates. Microbiology spectrum 10 (3) (2022)
Sara Hernando-Amado, Carla López-Causapé, Pablo Laborda, Fernando Sanz-García, Antonio Oliver, José-Luis Martínez
Rapid Phenotypic Convergence towards Collateral Sensitivity in Clinical Isolates of Pseudomonas aeruginosa Presenting Different Genomic Backgrounds. Microbiology spectrum 11 (1) (2022)
Sara Hernando-Amado, Carla López-Causapé, Pablo Laborda, Fernando Sanz-García, Antonio Oliver, José-Luis Martínez
Rapid Phenotypic Convergence towards Collateral Sensitivity in Clinical Isolates of Pseudomonas aeruginosa Presenting Different Genomic Backgrounds. Microbiology spectrum 11 (1) (2022)
Alba Ruedas-López, Isaac Alonso-García, Cristina Lasarte-Monterrubio, Paula Guijarro-Sánchez, Eva Gato, Juan Carlos Vázquez-Ucha, Juan Andrés Vallejo, Pablo Arturo Fraile-Ribot, Begoña Fernández-Pérez, David Velasco, José María Gutiérrez-Urbón, Marina Oviaño, Alejandro Beceiro, Concepción González-Bello, Antonio Oliver, Jorge Arca-Suárez, Germán Bou
Selection of AmpC β-Lactamase Variants and Metallo-β-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections. Antimicrobial agents and chemotherapy 66 (2) (2021)
Mercedes García-Gasalla, Joana Ferrer Balaguer, Pablo Arturo Fraile-Ribot, Adrián Ferre-Beltrán, Adrián Rodríguez, Natalia Martínez-Pomar, Luisa Ramon-Clar, Amanda Iglesias, Inés Losada, Francisco Fanjul, Joan Albert Pou, Isabel Llompart-Alabern, Nuria Toledo-Pons, Jaime Pons, Antonio Oliver, Melchor Riera Jaume, Javier Murillas
Predictive Immunological, Virological, and Routine Laboratory Markers for Critical COVID-19 on Admission. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 2021 (2021)
Nathan B Pincus, Egon Anderson Ozer, Jonathan P Allen, Marcus Nguyen, James J Davis, Deborah R Winter, Chih-Hsien Chuang, Cheng-Hsun Chiu, Laura Zamorano, Antonio Oliver, Alan R Hauser
Erratum for Pincus et al., "A Genome-Based Model to Predict the Virulence of Pseudomonas aeruginosa Isolates". mBio 12 (1) (2021)
Andrew R Mack, Melissa D Barnes, Magdalena A Taracila, Andrea M Hujer, Kristine M Hujer, Gabriel Cabot, Michael Feldgarden, Daniel H Haft, William Klimke, Focco van den Akker, Alejandro J Vila, Andrea Smania, Shozeb Haider, Krisztina M Papp-Wallace, Patricia A Bradford, Gian Maria Rossolini, Jean-Denis Docquier, Jean-Marie Frère, Moreno Galleni, Nancy D Hanson, Antonio Oliver, Patrick Plésiat, Laurent Poirel, Patrice Nordmann, Timothy G Palzkill, George A Jacoby, Karen Bush, Robert A Bonomo
A Standard Numbering Scheme for Class C β-Lactamases. Antimicrobial agents and chemotherapy 64 (3) (2020)
Hajira Bilal, Phillip J Bergen, Jessica R Tait, Steven C Wallis, Anton Y Peleg, Jason Alexander Roberts, Antonio Oliver, Roger L Nation, Cornelia B Landersdorfer
Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm Model. Antimicrobial agents and chemotherapy 64 (7) (2020)
Pablo A Fraile-Ribot, Laura Zamorano, Rocío Orellana, Ester Del Barrio-Tofiño, Irina Sánchez-Diener, Sara Cortes-Lara, Carla López-Causapé, Gabriel Cabot, Germán Bou, Luis Martínez-Martínez, Antonio Oliver, null null
Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and Isogenic β-Lactam-Resistant Mutants. Antimicrobial agents and chemotherapy 64 (2) (2020)
Nathan B Pincus, Egon Anderson Ozer, Jonathan P Allen, Marcus Nguyen, James J Davis, Deborah R Winter, Chih-Hsien Chuang, Cheng-Hsun Chiu, Laura Zamorano, Antonio Oliver, Alan R Hauser
A Genome-Based Model to Predict the Virulence of Pseudomonas aeruginosa Isolates. mBio 11 (4) (2020)
Cole L Slater, Judith Winogrodzki, Pablo A Fraile-Ribot, Antonio Oliver, Mazdak Khajehpour, Brian L Mark
Adding Insult to Injury: Mechanistic Basis for How AmpC Mutations Allow Pseudomonas aeruginosa To Accelerate Cephalosporin Hydrolysis and Evade Avibactam. Antimicrobial agents and chemotherapy 64 (9) (2020)
Juan Pablo Horcajada, María Milagro Montero, Antonio Oliver, Luisa Sorlí, Sònia Luque, Silvia Gómez-Zorrilla, Natividad Benito, Santiago Grau
Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections. Clinical microbiology reviews 32 (4) (2019)
Gabriel Torrens, Sara Belén Hernández, Juan Alfonso Ayala, Bartolome Moya, Carlos Juan, Felipe Cava, Antonio Oliver
Regulation of AmpC-Driven β-Lactam Resistance in Pseudomonas aeruginosa: Different Pathways, Different Signaling. mSystems 4 (6) (2019)
Jorge Arca-Suárez, Pablo Fraile-Ribot, Juan Carlos Vázquez-Ucha, Gabriel Cabot, Marta Martínez-Guitián, Emilio Lence, Concepción González-Bello, Alejandro Beceiro, Manuel Rodríguez-Iglesias, Fátima Galán-Sánchez, Germán Bou, Antonio Oliver
Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone. Antimicrobial agents and chemotherapy 63 (10) (2019)
Pablo A Fraile-Ribot, Cristóbal Del Rosario-Quintana, Carla López-Causapé, María A Gomis-Font, Mar Ojeda-Vargas, Antonio Oliver
Emergence of Resistance to Novel β-Lactam-β-Lactamase Inhibitor Combinations Due to Horizontally Acquired AmpC (FOX-4) in Pseudomonas aeruginosa Sequence Type 308. Antimicrobial agents and chemotherapy 64 (1) (2019)
Vanessa E Rees, Juergen B Bulitta, Antonio Oliver, Roger L Nation, Cornelia B Landersdorfer
Evaluation of Tobramycin and Ciprofloxacin as a Synergistic Combination Against Hypermutable Pseudomonas Aeruginosa Strains via Mechanism-Based Modelling. Pharmaceutics 11 (9) (2019)
Bartolome Moya, Isabel M Barcelo, Gabriel Cabot, Gabriel Torrens, Snehal Palwe, Prashant Joshi, Kushal Umarkar, Swapna Takalkar, Hariharan Periasamy, Sachin Bhagwat, Mahesh Patel, German Bou, Antonio Oliver
In Vitro and In Vivo Activities of β-Lactams in Combination with the Novel β-Lactam Enhancers Zidebactam and WCK 5153 against Multidrug-Resistant Metallo-β-Lactamase-Producing Klebsiella pneumoniae. Antimicrobial agents and chemotherapy 63 (5) (2019)
Juan Carlos Vázquez-Ucha, Marta Martínez-Guitián, María Maneiro, Kelly Conde-Pérez, Laura Álvarez-Fraga, Gabriel Torrens, Antonio Oliver, John D Buynak, Robert A Bonomo, Germán Bou, Concepción González-Bello, Margarita Poza, Alejandro Beceiro
Therapeutic Efficacy of LN-1-255 in Combination with Imipenem in Severe Infection Caused by Carbapenem-Resistant Acinetobacter baumannii. Antimicrobial agents and chemotherapy 63 (10) (2019)
Vanessa E Rees, Deanna S Deveson Lucas, Carla López-Causapé, Yuling Huang, Tom Kotsimbos, Juergen B Bulitta, Murray C Rees, Adele Barugahare, Anton Y Peleg, Roger L Nation, Antonio Oliver, John D Boyce, Cornelia B Landersdorfer
Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia. Antimicrobial agents and chemotherapy 63 (4) (2019)
Hajira Bilal, Phillip J Bergen, Tae Hwan Kim, Seung Eun Chung, Anton Y Peleg, Antonio Oliver, Roger L Nation, Cornelia B Landersdorfer
Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model. Antimicrobial agents and chemotherapy 63 (11) (2019)
Carla López-Causapé, Rosa Rubio, Gabriel Cabot, Antonio Oliver
Evolution of the Pseudomonas aeruginosa Aminoglycoside Mutational Resistome In Vitro and in the Cystic Fibrosis Setting. Antimicrobial agents and chemotherapy 62 (4) (2018)
Vanessa E Rees, Rajbharan Yadav, Kate E Rogers, Juergen B Bulitta, Veronika Wirth, Antonio Oliver, John D Boyce, Anton Y Peleg, Roger L Nation, Cornelia B Landersdorfer
Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients. Antimicrobial agents and chemotherapy 62 (11) (2018)
Cornelia B Landersdorfer, Vanessa E Rees, Rajbharan Yadav, Kate E Rogers, Tae Hwan Kim, Phillip J Bergen, Soon-Ee Cheah, John D Boyce, Anton Y Peleg, Antonio Oliver, Beom Soo Shin, Roger L Nation, Jürgen B Bulitta
Optimization of a Meropenem-Tobramycin Combination Dosage Regimen against Hypermutable and Nonhypermutable Pseudomonas aeruginosa via Mechanism-Based Modeling and the Hollow-Fiber Infection Model. Antimicrobial agents and chemotherapy 62 (4) (2018)
María Milagro Montero, Brian D VanScoy, Carla López-Causapé, Haley Conde, Jonathan Adams, Concepción Segura, Laura Zamorano, Antonio Oliver, Juan P Horcajada, Paul G Ambrose
Evaluation of Ceftolozane-Tazobactam in Combination with Meropenem against Pseudomonas aeruginosa Sequence Type 175 in a Hollow-Fiber Infection Model. Antimicrobial agents and chemotherapy 62 (5) (2018)
Carlos Juan, Gabriel Torrens, Isabel Maria Barceló, Antonio Oliver
Interplay between Peptidoglycan Biology and Virulence in Gram-Negative Pathogens. Microbiology and molecular biology reviews : MMBR 82 (4) (2018)
María Díez-Aguilar, María Isabel Morosini, Emin Köksal, Antonio Oliver, Miquel Ekkelenkamp, Rafael Cantón
Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms. Antimicrobial agents and chemotherapy 62 (1) (2017)
Pablo A Fraile-Ribot, Xavier Mulet, Gabriel Cabot, Ester Del Barrio-Tofiño, Carlos Juan, José L Pérez, Antonio Oliver
In Vivo Emergence of Resistance to Novel Cephalosporin-β-Lactamase Inhibitor Combinations through the Duplication of Amino Acid D149 from OXA-2 β-Lactamase (OXA-539) in Sequence Type 235 Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 61 (9) (2017)
Bartolome Moya, Isabel M Barcelo, Sachin Bhagwat, Mahesh Patel, German Bou, Krisztina M Papp-Wallace, Robert A Bonomo, Antonio Oliver
Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates. Antimicrobial agents and chemotherapy 61 (11) (2017)
Ester Del Barrio-Tofiño, Carla López-Causapé, Gabriel Cabot, Alba Rivera, Natividad Benito, Concepción Segura, María Milagro Montero, Luisa Sorlí, Fe Tubau, Silvia Gómez-Zorrilla, Nuria Tormo, Raquel Durá-Navarro, Esther Viedma, Elena Resino-Foz, Marta Fernández-Martínez, Claudia González-Rico, Izaskun Alejo-Cancho, Jose Antonio Martínez, Cristina Labayru-Echverria, Carlos Dueñas, Ignacio Ayestarán, Laura Zamorano, Luis Martinez-Martinez, Juan Pablo Horcajada, Antonio Oliver
Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain. Antimicrobial agents and chemotherapy 61 (11) (2017)
Irina Sánchez-Diener, Laura Zamorano, Carla López-Causapé, Gabriel Cabot, Xavier Mulet, Carmen Peña, Rosa Del Campo, Rafael Cantón, Antonio Doménech-Sánchez, Luis Martínez-Martínez, Susana C Arcos, Alfonso Navas, Antonio Oliver
Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegans Pseudomonas aeruginosa Infection Model. Antimicrobial agents and chemotherapy 61 (12) (2017)